183 related articles for article (PubMed ID: 6601709)
1. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
Whiteside TL; Medsger TA; Rodnan GP
J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
[TBL] [Abstract][Full Text] [Related]
2. Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma).
Lynch CJ; Singh G; Whiteside TL; Rodnan GP; Medsger TA; Rabin BS
J Clin Immunol; 1982 Oct; 2(4):314-8. PubMed ID: 6982903
[TBL] [Abstract][Full Text] [Related]
3. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
[TBL] [Abstract][Full Text] [Related]
4. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.
Kratz LE; Boughman JA; Needleman BW
Dis Markers; 1989; 7(4):209-13. PubMed ID: 2573446
[TBL] [Abstract][Full Text] [Related]
5. [Association of HLA antigens with scleroderma].
Kühnl P; Schütz K; Altmeyer P; Holzmann H; Seidl S
Z Hautkr; 1985 Jun; 60(11):866-8. PubMed ID: 3892952
[TBL] [Abstract][Full Text] [Related]
6. HLA antigens, autoantibodies and clinical subsets in scleroderma.
Black CM; Welsh KI; Maddison PJ; Jayson MI; Bernstein RM
Br J Rheumatol; 1984 Nov; 23(4):267-71. PubMed ID: 6593111
[TBL] [Abstract][Full Text] [Related]
7. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.
Satoh M; Akizuki M; Kuwana M; Mimori T; Yamagata H; Yoshida S; Homma M; Yamamoto T; Sasazuki T
J Rheumatol; 1994 Jan; 21(1):111-4. PubMed ID: 8151564
[TBL] [Abstract][Full Text] [Related]
8. Histocompatibility antigens in progressive systemic sclerosis (scleroderma).
Birnbaum NS; Rodnan GP; Rabin BS; Bassion S
J Rheumatol; 1977; 4(4):425-8. PubMed ID: 604479
[TBL] [Abstract][Full Text] [Related]
9. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity.
Szücs G; Szekanecz Z; Zilahi E; Kapitány A; Baráth S; Szamosi S; Végvári A; Szabó Z; Szántó S; Czirják L; György Kiss C
Rheumatology (Oxford); 2007 Jun; 46(6):989-93. PubMed ID: 17384178
[TBL] [Abstract][Full Text] [Related]
11. Immunogenetic analysis of 5 families with multicase occurrence of scleroderma and/or related variants.
Manolios N; Dunckley H; Chivers T; Brooks P; Englert H
J Rheumatol; 1995 Jan; 22(1):85-92. PubMed ID: 7699689
[TBL] [Abstract][Full Text] [Related]
12. HLA-antigen frequencies in patients with progressive systemic sclerosis and morphea.
Kühnl P; Sibrowski W; Kalmar G; Holzmann H; Sollberg S; Böhm BO
Beitr Infusionsther; 1990; 26():287-9. PubMed ID: 1703854
[TBL] [Abstract][Full Text] [Related]
13. [Class I and II HLA antigens in patients with systemic lupus erythematosus in the south of Spain].
Camps García MT; Ocón Sánchez P; Alonso Ortiz A; Belmonte López MA; García Portales R; Frutos Sanz MA; Guil García M; de Ramón Garrido E
Med Clin (Barc); 1994 May; 102(18):688-93. PubMed ID: 8028418
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.
Steen VD; Ziegler GL; Rodnan GP; Medsger TA
Arthritis Rheum; 1984 Feb; 27(2):125-31. PubMed ID: 6607734
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.
Pereira S; Black C; Welsh K; Ansell B; Jayson M; Maddison P; Rowell N
J Rheumatol; 1987 Aug; 14(4):760-5. PubMed ID: 3499513
[TBL] [Abstract][Full Text] [Related]
16. [Scleroderma and HLA antigens].
Holzmann H; Sollberg S; Schütz K; Kühnl P
Hautarzt; 1989 Mar; 40(3):134-40. PubMed ID: 2714991
[TBL] [Abstract][Full Text] [Related]
17. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
18. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
[TBL] [Abstract][Full Text] [Related]
19. [Circumscribed scleroderma: internal manifestations and significant correlation to HLA-DR1 and DR5].
Luderschmidt C; König G; Leisner B; Scholz S; Albert EE
Hautarzt; 1985 Sep; 36(9):516-21. PubMed ID: 3877710
[TBL] [Abstract][Full Text] [Related]
20. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
